Treatment With a Soluble Bone Morphogenetic Protein Type 1A Receptor (BMPR1A) Fusion Protein Increases Bone Mass and Bone Formation in Mice Subjected to Hindlimb Unloading

Previous work has shown that the soluble murine BMPR1A–fusion protein (mBMPR1A‐mFc) binds to BMP2 and BMP4 with high affinity, preventing downstream signaling. Further, treatment of intact and ovariectomized mice with mBMPR1A‐mFc leads to increased bone mass, and improved bone microarchitecture and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Frank C., Van Vliet, Miranda, Ellman, Rachel, Grasso, Daniel, Brooks, Daniel J, Spatz, Jordan M, Conlon, Chrissy, Aguirre, J Ignacio, Wronski, Thomas J, Bouxsein, Mary L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124165/
https://www.ncbi.nlm.nih.gov/pubmed/30283882
http://dx.doi.org/10.1002/jbm4.10012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124165/
https://www.ncbi.nlm.nih.gov/pubmed/30283882
http://dx.doi.org/10.1002/jbm4.10012

Ejemplares similares